Alan Williams
Directeur des opérations chez Adela, Inc.
Profil
Alan Williams is currently the Chief Operating Officer at Adela, Inc. He previously worked as the Vice President-Informatics at Affymetrix, Inc. from 2009 to 2010, Head-Ion Torrent Research & Development at Thermo Fisher Scientific, Inc. from 2014 to 2015, and Chief Development Officer at SomaLogic, Inc. from 2020 to 2023.
Dr. Williams received his undergraduate degree from the University of California, Davis and his doctorate from the University of California, Riverside.
Postes actifs de Alan Williams
| Sociétés | Poste | Début |
|---|---|---|
Adela, Inc.
 Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Directeur des opérations | 11/05/2023 |
Anciens postes connus de Alan Williams
| Sociétés | Poste | Fin |
|---|---|---|
| STANDARD BIOTOOLS INC. | Corporate Officer/Principal | 01/03/2023 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01/04/2015 |
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01/03/2010 |
Formation de Alan Williams
| University of California, Davis | Undergraduate Degree |
| University of California, Riverside | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| STANDARD BIOTOOLS INC. | Commercial Services |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Adela, Inc.
Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Finance |